Interview:CNBGvaccineprotectsagainstvariantcoronavirusstrains:companychairman-PeoplesDailyOnline

Saturday, Jan 16, 2021SearchArchiveChineseChinese
Japanese
French
Spanish
Russian
Arabic
Korean
German
PortugueseHomeOpinionsBusinessMilitaryWorldSocietyCultureTravelScienceSportsSpecial CoveragePhotoVideoEnglishInterview: CNBG vaccine protects against variant coronavirus strains: company chairman(Xinhua)    09:18, January 16, 2021A staff member checks a COVID-19 inactivated vaccine product at a packaging plant of the Beijing Biological Products Institute Co., Ltd. in Beijing, capital of China, Dec. 25, 2020.(Xinhua/Zhang Yuwei)BEIJING, Jan. 15 (Xinhua) -- The inactivated vaccine developed by China National Biotec Group (CNBG) affiliated with Sinopharm is broad-spectrum and can cross-neutralize different coronavirus strains, CNBG chairman Yang Xiaoming told Xinhua in a recent interview."Tests for the mutant strains found in Britain are in progress, and the preliminary results are good. It (the vaccine) can induce protection," said Yang.China granted conditional market approval for the vaccine developed by the Beijing Biological Products Institute Co., Ltd. under the CNBG last month. It showed 79.34 percent efficacy against COVID-19, and the seroconversion rate of neutralizing antibodies reached 99.52 percent, according to the interim results of the phase-3 clinical trials.According to Yang, more than 10 million doses of self-developed vaccines have been administered in China, with the side effects mainly limited to pain at the injection site, headache, muscle pain and fever.He said that the CNBG vaccine can induce antibodies against the coronavirus 10 days after the first shot, but there is a big difference in the antibody level in different people. The antibodies will reach a higher level 14 days after the second shot, providing adequate protection against the virus.Yang added that the CNBG explored different vaccination procedures and doses in the clinical trials. The results showed that the vaccine has the best effect when the second shot is three or four weeks after the first one."The CNBG is closely observing the length of protection its vaccine can offer," noted Yang.The earliest group was given the vaccine eight months ago, and it is still working. According to the data so far, the CNBG vaccine can offer protection for at least six months, and the company is still testing whether it can defend against the virus for eight months or more.As for whether children can get the CNBG vaccine, Yang said that so far the company has found no significant difference between different age groups in terms of safety and effectiveness. Children aged from 3 to 17 years can get the CNBG vaccine, he said.Yang noted that, for children aged from 3 to 5 years, the immune system is still at the development stage. They should be carefully observed when they are vaccinated.In addition to the inactivated vaccine developed in Beijing, the CNBG has developed another one through the Wuhan Institute of Biological Products, which is still awaiting approval.According to Yang, the CNBG has built high-level biosafety production workshops in Beijing and Wuhan. The production capacity is expected to reach more than 1 billion doses this year.Yang said the company has a large number of overseas orders. It spares no efforts to expand production on the premise of a stable production process, safety and effectiveness that meet the requirements of Chinas drug regulatory systems and quality indicators.var addthis_config = {"data_track_addressbar":false};(For the latest China news, Please follow Peoples Daily on Twitter and Facebook)(Web editor: Xian Jiangnan, Bianji)Add your comment/* * * CONFIGURATION VARIABLES: EDIT BEFORE PASTING INTO YOUR WEBPAGE * * */var shortname=window.location.host;var disqus_shortname=;var disqus_identifier=;if (shortname==en.people.cn){disqus_shortname=enpeople;disqus_identifier = 9810146;}/* * * DONT EDIT BELOW THIS LINE * * */(function() {var dsq = document.createElement(script); dsq.type = text/javascript; dsq.async = true;dsq.src = // + disqus_shortname + .disqus.com/embed.js;(document.getElementsByTagName(head)[0] || document.getElementsByTagName(body)[0]).appendChild(dsq);})();Please enable JavaScript to view the comments powered by Disqus.Most Read1 American-style democracy faces backlash2Chinese chipmakers eye global glory3Foreigners see Chinas victory against poverty on trip4Chinese researchers discover new anti-aging gene therapy5Guided-frigates conduct training in South China SeaHot NewsZhuang brocade: brothers continue a legacy while tackling poverty
Chinese peacekeepers embarking on missions for world peace
Love story of Zhang Dingyu, medical expert awarded national honorary title
SW China’s Yunnan province develops street market into wind vane of domestic flower market
China’s has consistent policy stance on developing China-U.S. relationsWe RecommendChina to have over 600,000 5G base stations in 2020
Beijing to complete construction of 10 venues for 2022 Winter Olympic Games by year end
China puts lives above everything amid COVID-19, saves lives at all cost
China’s investment in Belt and Road countries up 31.5 percent
China establishes modernized grain storage system to ensure food securityPhotosAward-winning photos show poverty reduction achievements in NE Chinas Jilin province
People dance to greet advent of New Year in Ameiqituo Town, Guizhou
Fire brigade in Shanghai holds group wedding
Tourists enjoy ice sculptures in Datan Town, north China
Sunset scenery of Dayan Pagoda in Xian
Tourists have fun at scenic spot in Nanlong Town, NW China
Harbin attracts tourists by making best use of ice in winter
In pics: FIS Alpine Ski Womens World Cup Slalom
Black-necked cranes rest at reservoir in Lhunzhub County, Lhasa
Chinas FAST telescope will be available to foreign scientists in AprilRelated readingOxford COVID-19 vaccine boss warns Australia against delaying immunizationsBeijing to complete administering first dose of COVID-19 vaccine among key groups by FridayUse of COVID-19 vaccines follows strict requirements, procedures: HKSAR govtEquitable access to vaccines now WHOs most urgent focus: TedrosTurkish president gets COVID-19 vaccineTurkey begins mass COVID-19 vaccination with Sinovacs jabsIndonesia starts massive COVID-19 vaccination drive with Sinovac jabsPhilippines prefers Chinese COVID-19 vaccines, calling them "safe, sure and secure"Philippines approves Pfizer-BioNTech vaccine for emergency useQuestions raised ahead of Australias rollout of Oxford-AstraZeneca vaccineLinks:People’s Daily AppBeijing TodayCRI EnglishSINA EnglishGlobal TimesChinadaily.com.cn Taiwan.cn Ecns.cn Show ChinaChina Human RightsChina XinjiangTibet OnlineCCTV Beijing Review GMW.cnChina Economic Net
China Tibet Online
Qiushi JournalWomen of China
Consulate General in New York.link_content{overflow:hidden;}
About Peoples Daily Online |Join Us | Contact Us
people.cn © Peoples Daily Onlinevar str="Interview: CNBG vaccine protects against variant coronavirus strains: company chairman";
var str1="Interview: CNBG vaccine protects against variant coronavirus strains: company chairman";
str=str.replace(/ /g," ")
str=str.replace(/"/g,")
str=str.replace(//g,"")
str1=str1.replace(/ /g," ")
str1=str1.replace(/"/g,")
str1=str1.replace(//g,"")
var wxData = {"imgUrl": "http://www.people.com.cn/img/2016wb/images/logo_share.jpg", // 200x200"link": window.location.href,"desc": "" + str + "","title": "" + str1 + ""
};

Leave a Reply

Your email address will not be published. Required fields are marked *

sixteen + 8 =